The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Keap1 Recruits Neh2 through Binding to ETGE and DLG Motifs: Characterization of the Two-Site Molecular Recognition Model
Open accessAbstract
The expression of the phase 2 detoxification enzymes and antioxidant proteins is induced at the transcriptional level by Nrf2 and negatively regulated at the posttranslational level by Keap1 through protein-protein interactions with and subsequent proteolysis of Nrf2. We found that the Neh2 domain of Nrf2 is an intrinsically disordered but biologically active regulatory domain containing a 33-residue central alpha-helix followed by a mini antiparallel beta-sheet. Isothermal calorimetry analysis indicated that one Neh2 molecule interacts with two molecules of Keap1 via two binding sites, the stronger binding ETGE motif and the weaker binding DLG motif. Nuclear magnetic resonance titration study showed that these two motifs of the Neh2 domain bind to an overlapping site on the bottom surface of the beta-propeller structure of Keap1. In contrast, the central alpha-helix of the Neh2 domain does not have any observable affinity to Keap1, suggesting that this region may serve as a bridge connecting the two motifs for the association with the two beta-propeller structures of a dimer of Keap1. Based on these observations, we propose that Keap1 recruits Nrf2 by the ETGE motif and that the DLG motif of the Neh2 domain locks its lysine-rich central alpha-helix in a correct position to benefit ubiquitin signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Keap1 recruits Nrf2 first through the binding of one Keap1 molecule to the high-affinity ETGE motif within the Nrf2’s Neh2 domain. Subsequent binding of the other Keap1 molecule at the low-affinity DLG motif locks Nrf2 in place by orienting the lysine residues within Neh2 in the correct position for ubiquitination by Cul3 and degradation by the 26S proteasome [58,65].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [58]
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,961
NMR with Proteins and Nucleic Acids
Wüthrich, K. (1986) · Europhysics news · doi:10.1051/epn/19861701011 · Cited by 8,028
NMR of Proteins and Nucleic Acids
(2006) · Royal Society of Chemistry eBooks · doi:10.1039/9781847555236-00336 · Cited by 5,874
Investigation of exchange processes by two-dimensional NMR spectroscopy
Jeener, J., Meier, B. H., Bachmann, P., & Ernst, R. R. (1979) · The Journal of Chemical Physics · doi:10.1063/1.438208 · Cited by 4,750
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Intrinsically unstructured proteins and their functions
Dyson, H. J., & Wright, P. E. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1589 · Cited by 3,871
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Self-citationHayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,565
Pervushin, K. V., Riek, R., Wider, G., & Kurt Wüthrich, A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12366 · Cited by 2,450
Kay, L. E., Keifer, P. A., & Saarinen, T. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00052a088 · Cited by 2,261
Research works printed but not linked: 1
- Garrett D. S., 1991, J. Magn. Reson., 95, 214
Cited by
Sorted by citations
Items 401–500 of 780
Zhang, X., Zhao, N., Guo, F., Wang, Y., Liu, S.-X., & Zeng, T. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112760 · Cited by 35
Oxidative Stress-Induced Misfolding and Inclusion Formation of Nrf2 and Keap1
Ngo, V., Karunatilleke, N. C., Brickenden, A. M., Choy, W., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11020243 · Cited by 36
“Numerous domains of Nrf2 have previously been characterized as intrinsically disordered [14, 16] and our data support this.”
BackgroundResultInfluentialLi, Y., Zhu, X., Wang, K., Zhu, L., Murray, M. T., & Zhou, F. (2022) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgac036 · Cited by 37
Polar Recognition Group Study of Keap1-Nrf2 Protein–Protein Interaction Inhibitors
Lu, M., Tan, S.-J., Ji, J., Chen, Z., Yuan, Z., You, Q., & Jiang, Z. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00407 · Cited by 35
The β -TrCP-Mediated Pathway Cooperates with the Keap1-Mediated Pathway in Nrf2 Degradation In Vivo
Kuga, A., Tsuchida, K., Panda, H., Horiuchi, M., Otsuki, A., Taguchi, K., Katsuoka, F., Suzuki, M., & Yamamoto, M. P. (2022) · Molecular and Cellular Biology · doi:10.1128/mcb.00563-21 · Cited by 34
Self-citationSatoh, M., Saburi, H., Tanaka, T. U., Matsuura, Y., Naitow, H., Shimozono, R., Yamamoto, N., Inoue, H., Nakamura, N., Yoshizawa, Y., et al. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.06.011 · Cited by 35
Self-citationMartínez, V. D., Vucic, E. A., Thu, K. L., Pikor, L. A., Hubaux, R., & Lam, W. L. (2014) · BioMed Research International · doi:10.1155/2014/159459 · Cited by 34
Deng, H., & Kerppola, T. K. (2014) · Development · doi:10.1242/dev.110528 · Cited by 35
“This is in contrast to the hypothesis thatmammalianKeap1 interacts withNrf2 as a homodimer (Tong et al., 2006; Ogura et al., 2010).”
ResultSchaap, M., Hancock, R., Wilderspin, A. F., & Wells, G. (2013) · Protein Science · doi:10.1002/pro.2384 · Cited by 33
Mathematical modeling reveals quantitative properties of KEAP1-NRF2 signaling
Liu, S., Pi, J., & Zhang, Q. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102139 · Cited by 35
“In the literature, its binding kinetics was determined in vitro by using mouse KEAP1-DC fragment and NRF2-Neh2 domain fragment [29] or extended DLG motif peptide (DLGex) [35].”
BackgroundMethodInfluentialNaidu, S. D., Suzuki, T., Dikovskaya, D., Knatko, E. V., Higgins, M., Sato, M., Novak, M. J., Villegas, J. A., Moore, T. W., Yamamoto, M. P., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103703 · Cited by 33
“…of Nrf2 via two sites located in the N-terminal Neh2 domain of Nrf2, a low-affinity ‘‘DLG’’ motif, and a high-affinity ‘‘ETGE’’ motif (McMahon et al., 2006; Tong et al., 2006), whereby acidic residues in these twomotifs interact electrostatically with a triad of arginine residues (Arg380, Arg415,…”
BackgroundSelf-citationEffect of Nrf2 on rat ovarian tissues against atrazine-induced anti-oxidative response.
Zhao, F., Li, K., Zhao, L., Liu, J., Suo, Q., Zhao, J., Wang, H., & Zhao, S. (2014) · PubMed Central · Cited by 33
Binding of disordered proteins to a protein hub
Cino, E. A., Killoran, R. C., Karttunen, M., & Choy, W. (2013) · Scientific Reports · doi:10.1038/srep02305 · Cited by 33
A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease
Hammoutène, A., Laouirem, S., Albuquerque, M., Colnot, N., Brzustowski, A., Valla, D. C., Provost, N., Delerive, P., & Paradis, V. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100845 · Cited by 37
The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario
Mukherjee, A. G., & Gopalakrishnan, A. V. (2023) · Medical Oncology · doi:10.1007/s12032-023-02124-4 · Cited by 33
“The Neh2 domain is situated in the N-terminal region and comprises the amino acid motifs ETGE and DLG, which exhibit a crucial function in binding with Kelch-like ECH-associated protein 1 (Keap1) [5].”
BackgroundNovel and efficient techniques in the discovery of antioxidant peptides
Zhang, Y., Li, Y., Ren, T., Xiao, P., & Duan, J. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2245052 · Cited by 32
“Moreover, the ETGE motif is approximately 100-fold stronger in affinity to Keap1 than the DLG motif (K.I. Tong et al. 2006).”
Qin, S., & Hou, D. (2017) · Engineering · doi:10.1016/j.eng.2017.03.011 · Cited by 34
Raghunath, A., Raju, N., Sundarraj, K., Palanisamy, K., & Perumal, E. (2019) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13222 · Cited by 33
Nuclear factor erythroid 2-related factor 2 (Nrf2) as a potential therapeutic target for vitiligo
Lin, X., Meng, X., Song, Z., & Lin, J. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108670 · Cited by 32
Role of Nrf2 in Pancreatic Cancer
Cykowiak, M., & Krajka‐Kuźniak, V. (2021) · Antioxidants · doi:10.3390/antiox11010098 · Cited by 31
“The results of nuclear magnetic resonance spectroscopy have shown that the Neh2 region of Nrf2 is predicted to be intrinsically disordered but capable of binding to the fulllength Keap1 protein at low nanomolar concentrations [31].”
BackgroundYasuda, D., Yuasa, A., Obata, R., Nakajima, M., Takahashi, K., Ohe, T., Ichimura, Y., Komatsu, M., Yamamoto, M. P., Imamura, R. M., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.10.008 · Cited by 33
Self-citationZhang, Z., Guo, Z., Zhan, Y., Li, H., & Wu, S. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.10.011 · Cited by 31
“When the intracellular oxide accumulates in the cell, a large number of Nrf2–keap1 complexes in the cytoplasm are dissociated and then transferred to the nucleus in combination with ARE (Tong et al., 2006).”
BackgroundTamberg, N., Tahk, S., Koit, S., Kristjuhan, K., Kasvandik, S., Kristjuhan, A., & Ilves, I. (2018) · Scientific Reports · doi:10.1038/s41598-018-30562-y · Cited by 32
Adamson, R. J., Payne, N. C., Bartual, S. G., Mazitschek, R., & Bullock, A. N. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.04.021 · Cited by 30
“There have also been conflicting reports on the stoichiometry of the KEAP1-CUL3 complex [46,47].”
Cheng, C., Zhang, J., Liu, K., Xu, Y., Shen, F., Han, Y., Hou, Y., Zhang, T., & Bai, G. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154992 · Cited by 31
Sharma, P., & Varshney, R. K. (2012) · Free Radical Research · doi:10.3109/10715762.2012.724771 · Cited by 31
Tong, Y., Liu, S., Gong, R., Zhong, L., Duan, X., & Zhu, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2129350 · Cited by 31
“Then, the activated Nrf2 is entered into the nucleus and interacts with antioxidant response element to promote the transcription of downstream target genes coding for cytoprotective proteins, such as GSH-Px, CAT, and SOD, for antioxidation and detoxication [45, 46], which is consistent with our previous studies.”
ResultPadmanabhan, B., Tong, K. I., Kobayashi, A., Yamamoto, M. P., & Yokoyama, S. (2008) · Journal of Synchrotron Radiation · doi:10.1107/s090904950705114x · Cited by 31
Self-citationBaird, L., & Yamamoto, M. P. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102904 · Cited by 31
“Under non-stressed conditions, KEAP1 targets NRF2 for ubiquitination and proteasome-dependent degradation, which, under homeostatic conditions, maintains NRF2-target gene expression at low levels [6,7].”
BackgroundSelf-citationAnthocyanins As Modulators of Cell Redox-Dependent Pathways in Non-Communicable Diseases
Speciale, A., Saija, A., Bashllari, R., Molonia, M. S., Muscarà, C., Occhiuto, C., Cimino, F., & Cristani, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181112093336 · Cited by 31
Small Molecular Nrf2 Inhibitors as Chemosensitizers for Cancer Therapy
Lin, H., Qiao, Y., Yang, H., Nan, Q., Qu, W., Feng, F., Liu, W., Chen, Y., & Sun, H. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0285 · Cited by 30
Ni, B., Chen, Z., Shu, L., Shao, Y., Huang, Y., Tamrat, N. E., Wei, Z., & Shen, B. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4009308 · Cited by 30
“Under homeostatic conditions, two molecules of keap1 are bound to Nrf2 and isolate Nrf2 in the cytoplasm [8].”
BackgroundMechanism of Cullin3 E3 Ubiquitin Ligase Dimerization
Choo, Y. Y., & Hagen, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041350 · Cited by 30
“. Keap1 protein homodimerizes to recognize two separate motifs, the ETGE and DLG motifs, in its substrate Nrf2”
BackgroundNew strategies to inhibit KEAP1 and the Cul3-based E3 ubiquitin ligases
Canning, P., & Bullock, A. N. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130215 · Cited by 29
Tamir, T. Y., Bowman, B. M., Agajanian, M. J., Goldfarb, D., Schrank, T. P., Stohrer, T., Hale, A., Siesser, P. F., Weir, S., Murphy, R. M., et al. (2020) · Journal of Cell Science · doi:10.1242/jcs.241356 · Cited by 29
Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction
Colarusso, S., Simone, D. D., Frattarelli, T., Andreini, M., Cerretani, M., Missineo, A., Moretti, D., Tambone, S., Kempf, G., Augustin, M. A., et al. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115738 · Cited by 29
Dual role of Nrf2 in cancer: molecular mechanisms, cellular functions and therapeutic interventions
Poornashree, M., Kumar, H., AJMEER, R., Jain, R., & Jain, V. K. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08126-1 · Cited by 28
“Under the most fundamental circumstance, the synergy of Nrf2 with 2 fragments of Keap1 via its Neh2, DLG & ETGE domains for the activation of the cullin 3-based E3 ligase complex are observed in the Nrf2-conciliated ubiquitination reaction [35].”
BackgroundChauhan, N., Chaunsali, L., Deshmukh, P. H., & Padmanabhan, B. (2013) · Bioinformation · doi:10.6026/97320630009450 · Cited by 29
Perfluoroarene-based peptide macrocycles that inhibit the Nrf2/Keap1 interaction
Steel, R., O'Connell, M. A., & Searcey, M. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.03.003 · Cited by 29
Georgakopoulos, N., Talapatra, S., Dikovskaya, D., Dayalan Naidu, S., Higgins, M., Gatliff, J., Ayhan, A., Nikoloudaki, R., Schaap, M., Valko, K., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00457 · Cited by 33
Zou, J., Yan, J., Lu, Y., Zhou, Y., Zhang, K., Han, Q., Han, D., Gai, C., Chai, X., Zhao, Q., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00065 · Cited by 28
Peptide design to control protein–protein interactions
Wier, S. P. V., & Beekman, A. M. (2025) · Chemical Society Reviews · doi:10.1039/d4cs00243a · Cited by 34
Jiang, Z., Xu, L., Lu, M., Pan, Y., Huang, H., Zhang, X., Sun, H.-P., & You, Q. (2014) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9799-y · Cited by 28
Perspectives on the Clinical Development of NRF2-Targeting Drugs
Lastra, D., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_381 · Cited by 29
Signaling pathways and proteins targeted by antidiabetic chalcones
Adelusi, T. I., Du, L., Chowdhury, A., Gu, X., Lü, Q., & Yin, X. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118982 · Cited by 29
He, L., & Sun, Y. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00762-z · Cited by 30
An updated patent review of Nrf2 activators (2020-present)
Zhao, Z., Dong, R., Cui, K., You, Q., & Jiang, Z. (2023) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2023.2178299 · Cited by 28
Shimomura, Y., Takaki, A., Wada, N., Yasunaka, T., Ikeda, F., Maruyama, T., Tamaki, N., Uchida, D., Onishi, H., Kuwaki, K., et al. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.7002 · Cited by 28
“Another antioxidant, transcriptional factor Nrf2, binds to Kelch-like ECH associating protein 1 (Keap 1), which is located in the cytoplasm in an inactive form (26).”
BackgroundZhao, Z., Dong, R., You, Q., & Jiang, Z. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00712 · Cited by 28
Martinez‐Canton, M., Galván-Álvarez, V., Martín-Rincón, M., Calbet, J. A. L., & Gallego-Selles, Á. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.08.011 · Cited by 29
Regulation of stress signaling pathways by nitro-fatty acids
Deen, A. J., Sihvola, V., Härkönen, J., Patinen, T., Adinolfi, S., & Levonen, A. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.03.012 · Cited by 27
Zhou, Y., Zhou, Y., Wang, K., Li, T., Yang, M., Wang, R., Chen, Y., Cao, M., & Hu, R. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.010 · Cited by 27
Lee, S., Abed, D. A., Nguyen, M.-U., Verzi, M. P., & Hu, L. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114380 · Cited by 27
Rahman, L. N., Bamm, V. V., Voyer-Grant, J. A. M., Smith, G. S. T., Chen, L., Yaish, M. W. F., Moffatt, B. A., Dutcher, J., & Harauz, G. (2010) · Amino Acids · doi:10.1007/s00726-010-0759-0 · Cited by 27
“The data were fitted to the Origin ‘‘one set of sites’’ model for both proteins, although the ‘‘two sets of independent sites’’ model was also investigated for TsDHN-1 (cf., Majava et al. 2008; Tong et al. 2006; Velazquez-Campoy et al. 2004).”
MethodInfluentialSon, Y., Pratheeshkumar, P., Wang, Y., Kim, D., Zhang, Z., & Shi, X. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.04.016 · Cited by 27
“Previous studies showed that Nrf2 is able to bind to the ARE in the promoter region of the Bcl-2 gene, leading to an up-regulation of Bcl-2 and decrease in apoptosis (Calvert et al., 2009; Lau et al., 2013; Mukherjee et al., 2013; Ohta et al., 2008; Sporn and Liby, 2012; Tong et al., 2006).”
BackgroundInfluentialLi, W., Sun, K., Hu, F., Chen, L., Zhang, X., Wang, F., & Yan, B. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22658 · Cited by 27
Advances in KEAP1-based PROTACs as emerging therapeutic modalities: Structural basis and progress
Chen, J., Feng, D., Zhu, R., Li, H., & Chen, L. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103781 · Cited by 29
“4A) [35,45, 51].”
Liu, C., Wang, B., Zhou, B., Jian, X., Zhang, X., & Wang, Y. (2018) · Aquatic Toxicology · doi:10.1016/j.aquatox.2018.11.026 · Cited by 26
NRF2 , a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer
Panieri, E., Telkoparan‐Akillilar, P., & Saso, L. (2022) · BioFactors · doi:10.1002/biof.1912 · Cited by 27
“KEAP1 binds to Neh2 domain of NRF2 at ETGE and DLG motifs, and thus promotes its constitutive ubiquitination and proteasomal degradation.(29) KEAP1 is a cysteine-rich protein and contains several thiol groups that are susceptible of oxidation by electrophilic agents.”
BackgroundGuntas, G., Lewis, S. M., Mulvaney, K. M., Cloer, E. W., Tripathy, A., Lane, T. R., Major, M. B., & Kuhlman, B. A. (2015) · Protein Engineering Design and Selection · doi:10.1093/protein/gzv055 · Cited by 26
“Under basal conditions, NRF2 binds the Kelch domain of homodimeric KEAP1 (Kelch-like ECH-associated protein 1) through its high-affinity (Kd 5 nM) and low-affinity motifs (Kd 1 μM) (Lo et al., 2006; Tong et al., 2006).”
BackgroundQiao, Z., Lai, W., Lin, Y., Li, D., Nan, X., Wang, Y., Wang, H., & Fang, Q. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00176 · Cited by 26
Lu, M., Ji, J., Lv, Y., Zhao, J., Liu, Y., Jiao, Q., Liu, T., Mou, Y., You, Q., & Jiang, Z. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.12.005 · Cited by 26
NRF2 inhibitors: Recent progress, future design and therapeutic potential
Lv, B., Xing, S., Wang, Z., Zhang, A., Wang, Q., Bian, Y., Pei, Y., Sun, H., & Chen, Y. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116822 · Cited by 26
Lee, S., Abed, D. A., Beamer, L. J., & Hu, L. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220935816 · Cited by 25
The functions and effects of CUL3-E3 ligases mediated non-degradative ubiquitination
Zhai, F., Li, J., Ye, M., & Jin, X. (2022) · Gene · doi:10.1016/j.gene.2022.146562 · Cited by 24
Meng, Y., Lin, W. Y., Wang, N., Xiao, W., Huang, Q., & Liao, Y. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.01.004 · Cited by 25
Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease
Chauhan, W., & Zennadi, R. (2023) · Antioxidants · doi:10.3390/antiox12030740 · Cited by 27
“Similarly, the conserved DLG motif of Neh2 is located in a flexible region upstream of the core β-helix, and also binds Keap1-DC; however, with a noticeably reduced affinity [31].”
BackgroundXiao, H., Lu, F.-L., Stewart, D., & Zhang, Y. (2013) · Current Chemical Biology · doi:10.2174/2212796811307020008 · Cited by 25
A Novel Germline Mutation of KEAP1 (R483H) Associated with a Non-Toxic Multinodular Goiter
Nishihara, E., Hishinuma, A., Kogai, T., Takada, N., Hirokawa, M., Fukata, S., Ito, M., Yabuta, T., Nishikawa, M., Nakamura, H., et al. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00131 · Cited by 24
Bowman, B. M., Montgomery, S. A., Schrank, T. P., Simon, J. M., Ptacek, T., Tamir, T. Y., Mulvaney, K. M., Weir, S., Nguyen, T. T., Murphy, R. M., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5504 · Cited by 24
“Molecular characterization of the patient-derived NRF2 E79Q mutation Squamous cell carcinomas of the lung (LUSC), head and neck (HNSCC), and esophagus (ESCC) contain focally enriched NRF2 mutations around residues 29–31 and 79–81, which correspond to the DLG and ETGEbindingmotifs [5,41,42].”
BackgroundDecreased cortical Nrf2 gene expression in autism and its relationship to thiol and cobalamin status
Schrier, M. S., Zhang, Y., Trivedi, M. S., & Deth, R. C. (2021) · Biochimie · doi:10.1016/j.biochi.2021.09.006 · Cited by 24
Genetic Variations on Redox Control in Cardiometabolic Diseases: The Role of Nrf2
Zazueta, C., Jiménez‐Uribe, A. P., Pedraza‐Chaverrí, J., & Buelna‐Chontal, M. (2022) · Antioxidants · doi:10.3390/antiox11030507 · Cited by 27
“Neh2 domain is located at the aminoterminal and has ETGE and DLG motifs that interact with Kelch-like ECH-associated protein 1 (Keap1), the well-known negative regulator of Nrf2 [20].”
BackgroundVirtual Screening Expands the Non-Natural Amino Acid Palette for Peptide Optimization
Amarasinghe, K. N., Maria, L. D., Tyrchan, C., Eriksson, L. A., Sadowski, J., & Petrović, D. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00193 · Cited by 24
An Overview of Therapeutic Targeting of Nrf2 Signaling Pathway in Rheumatoid Arthritis
Saha, S. (2024) · ACS Omega · doi:10.1021/acsomega.4c00163 · Cited by 24
“39 Multiple extremely reactive cysteine residues found in Keap1, such as Cys151 in the BTB domain, Cys226, Cys273, and Cys288 in the IVR domain, and Cys613 at the Kelch domain, function as redox sensors.”
BackgroundHippocampal signaling pathways are involved in stress-induced impairment of memory formation in rats
Sardari, M., Rezayof, A., & Khodagholi, F. (2015) · Brain Research · doi:10.1016/j.brainres.2015.08.015 · Cited by 24
“Under unstressed conditions, Nrf2 can be anchored in the cytoplasm via binding to Kelch-like ECH-associated protein1 (Tong et al., 2006), while stress exposure leads to the release of Nrf2 from Keap-1 (Dinkova-Kostova et al.”
Molecular Mechanisms of Nickel-Induced Carcinogenesis
Son, Y. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666191125112728 · Cited by 25
Zhao, S., Wu, C., Li, W., Yu, W., Li, S., Rao, T., Ruan, Y., Zhou, X., Liu, C., Qi, Y., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16924 · Cited by 23
Counting Degrons: Lessons From Multivalent Substrates for Targeted Protein Degradation
Okoye, C. N., Rowling, P. J. E., Itzhaki, L. S., & Lindon, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.913063 · Cited by 26
Role of NRF2 in Colorectal Cancer Prevention and Treatment
Li, J., Wang, D., Liu, Y., & Zhou, Y. (2022) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221105736 · Cited by 24
“Keap1 promotes the ubiquitination of NRF2 in the cytoplasm and keeps it at a low level in the cytoplasm.(9) When exposed to oxidative stress or using an NRF2 activator, NRF2 is dissociated from Keap1 binding and then translocated to the nucleus, where it transcribes with sMaf protein polymer and ARE gene to activate t…”
BackgroundMkp-1 protects mice against toxin-induced liver damage by promoting the Nrf2 cytoprotective response
Luo, L., Chen, Y., Wang, H., Wang, S., Liu, K., Li, X., Wang, X. J., & Tang, X. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.010 · Cited by 23
Song, Q., Zhang, K., Li, S., & Weng, S. (2025) · Current Research in Food Science · doi:10.1016/j.crfs.2025.100977 · Cited by 22
Sahu, M., & Jain, U. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167764 · Cited by 24
Binding of Disordered Peptides to Kelch: Insights from Enhanced Sampling Simulations
Do, T. N., Choy, W., & Karttunen, M. (2015) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.5b00868 · Cited by 22
Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in non-small cell lung cancer
Zeng, Z., Wang, Z., Li, Y., Ye, D., Zeng, J., Hu, J., Chen, P.-F., Xiao, J., Zou, J., & Li, Z. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117325 · Cited by 22
Xie, J., Zhang, Y., Li, S., Wei, H., Yu, H., Zhou, Q., Wei, L., Ke, D., Wang, Q., Yang, Y., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1003 · Cited by 22
ARD1 stabilizes NRF2 through direct interaction and promotes colon cancer progression
Fang, X., Lee, Y., Jang, J., Kim, S., Kim, S. H., Kim, D., Na, H., Kim, K.-O., Baek, J., & Surh, Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121217 · Cited by 22
Park, S., Lee, M., Na, H., & Surh, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.10516 · Cited by 22
Son, Y.-O., Pratheeshkumar, P., Divya, S., Zhang, Z., & Shi, X.-L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.773986 · Cited by 19
“Constitutive activation of Nrf2 is evident in several human cancer cell lines as well as in tumors (35-38).”
BackgroundRetractedMa, Y. F., Wu, Z. H., Gao, M., & Loor, J. J. (2018) · Journal of Dairy Science · doi:10.3168/jds.2017-13954 · Cited by 22
The Nrf2/HO-1 axis can be a prognostic factor in clear cell renal cell carcinoma
Deng, Y., Wu, Y., Zhao, P., Weng, W., Ye, M., Sun, H. M., Xu, M., & Wang, C. (2019) · Cancer Management and Research · doi:10.2147/cmar.s188046 · Cited by 22
Chen, Z., Wasney, G. A., Picaud, S., Filippakopoulos, P., Vedadi, M., D’Angiolella, V., & Bullock, A. N. (2020) · Open Biology · doi:10.1098/rsob.200041 · Cited by 21
Bityutskyy, V., Tsekhmistrenko, S., Tsekhmistrenko, О., Tymoshok, N. O., & Spivak, M. Y. (2020) · Regulatory Mechanisms in Biosystems · doi:10.15421/022074 · Cited by 21
“Phosphorylation of Nrf2 by PI3K, PKC, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (ERK) provides up-regulation, while p38 MAPK (MAP kinase mitogen-activated protein kinase) regulates the Nrf2 pathway both positively and negatively (Yu et al., 2000; Huang et al., 2002; Kobayashi et al., 200…”
BackgroundInfluentialFAM129B‐dependent activation of NRF2 promotes an invasive phenotype in BRAF mutant melanoma cells
Schmidlin, C. J., Tian, W., Dodson, M. B., Chapman, E., & Zhang, D. D. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23295 · Cited by 21
Simov, V., Altman, M. D., Bianchi, E., DelRizzo, S., DiNunzio, E. N., Feng, G., Goldenblatt, P., Ingenito, R., Johnson, S. A., Mansueto, M. S., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113686 · Cited by 21
Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review
Singh, E., Matada, G. S. P., Abbas, N., Dhiwar, P. S., Ghara, A., & Das, A. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00860-5 · Cited by 21
“The amino acid sequence present in the C-terminal of Neh3 domain is a determining factor for activation of ARE.”
BackgroundInfluentialPros and cons of NRF2 activation as adjunctive therapy in rheumatoid arthritis
Manda, G., Milanesi, E., Genç, Ş., Niculite, C. M., Neagoe, I. V., Tastan, B., Dragnea, E. M., & Cuadrado, A. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.08.012 · Cited by 22
Ariffianto, A., Deng, L., Abe, T., Matsui, C., Ito, M., Ryo, A., Aly, H. H., Watashi, K., Suzuki, T., Mizokami, M., et al. (2023) · Journal of Virology · doi:10.1128/jvi.01287-23 · Cited by 22
“The DGR domain of Keap1, which mediates interaction with Nrf2 (25), was important for HBx-binding (Fig.”
BackgroundMurray, J. R., de la Vega, L., Hayes, J. D., Duan, L., & Penning, T. M. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00399 · Cited by 21
Nrf2 in Neoplastic and Non-Neoplastic Liver Diseases
Orrù, C., Giordano, S., & Columbano, A. (2020) · Cancers · doi:10.3390/cancers12102932 · Cited by 21
“The interaction between Keap1 and Nrf2 requires the Nrf2 DLG and ETGE domains: ETGE engages Nrf2 with Keap1, while the DLG motif acts as latch to (un)lock the Nrf2 Neh2 domain in an appropriate spatial orientation, and thus regulates Nrf2 stability and ubiquitination [4,5].”
BackgroundDietary Phytochemicals Targeting Nrf2 to Enhance the Radiosensitivity of Cancer
Wang, P., Long, F., Lin, H., Wang, S., & Wang, T. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7848811 · Cited by 22
“Among these functional domains, Neh2 was located in the N-terminal, which contains ETGE and DLG motifs for binding the inhibitory protein Kelch-like ECH-associated protein 1 (Keap1) [19 – 21].”
Metadata
- Authors
- Tong, K. I., Katoh, Y., Kusunoki, H., Itoh, K., Tanaka, T., & Yamamoto, M.
- Affiliations
- University of Tsukuba (JP)
- Corresponding author
- Tanaka, Toshiyuki
- Yamamoto, Masayuki
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2006-04-01
- Volume
- 26
- Issue
- 8
- Pages
- 2887-2900
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC1446969
- OpenAlex
- W2171218310
- Cited by
- 759
- References
- 71
- Citations by year
- 2026: 44 · 2025: 44 · 2024: 42 · 2023: 56 · 2022: 58 · 2021: 46 · 2020: 59 · 2019: 41 · 2018: 38 · 2017: 51 · 2016: 31 · 2015: 34 · 2014: 36 · 2013: 35 · 2012: 30
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Keap1, Nrf2, protein-protein interaction, two-site model, beta-propeller, intrinsically disordered proteins, ubiquitin ligase, post-translational regulation, antioxidant proteins
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Amino Acid Sequence, Animals, Binding Sites, Calorimetry, Cytoskeletal Proteins, Escherichia coli, Models, Chemical, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Processing, Post-Translational, Recombinant Fusion Proteins, Thermodynamics, Ultracentrifugation, Conserved Sequence, Point Mutation, Sequence Homology, Amino Acid, Protein Structure, Secondary, Protein Structure, Tertiary, Nuclear Magnetic Resonance, Biomolecular, Amino Acid Motifs, Adaptor Proteins, Signal Transducing, NF-E2-Related Factor 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review